Surrozen (SRZN) Change in Acquisitions & Divestments (2021 - 2023)
Surrozen (SRZN) posted quarterly Change in Acquisitions & Divestments of $9.5 million for Q4 2023, down 11.77% year-over-year from $10.8 million in Q4 2022, and down 44.12% quarter-over-quarter from $17.0 million in Q3 2023.
Surrozen (SRZN) Change in Acquisitions & Divestments (2021 - 2023) Analysis & Trends
Surrozen's Change in Acquisitions & Divestments history runs 3 years deep, the most recent figure standing at $9.5 million for Q4 2023.
- In Q4 2023, Change in Acquisitions & Divestments fell 11.77% year-over-year to $9.5 million; the TTM figure through Sep 2024 stood at $9.5 million (down 88.33% YoY), while the FY2023 annual figure was $80.2 million, up 16.8% from the prior year.
- Change in Acquisitions & Divestments for Q4 2023 stood at $9.5 million, down from $17.0 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $43.9 million in Q3 2022, with the low at $1.1 million in Q4 2021.
- The 3-year median for Change in Acquisitions & Divestments is $14.0 million (2022), against an average of $17.1 million.
- The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments surged 897.05% in 2022, then slumped 61.25% in 2023.
- Surrozen's Change in Acquisitions & Divestments stood at $1.1 million in 2021, then surged by 878.82% to $10.8 million in 2022, then dropped by 11.77% to $9.5 million in 2023.
- Business Quant data shows SRZN's Change in Acquisitions & Divestments at $9.5 million in Q4 2023, $17.0 million in Q3 2023, and $28.2 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Surrozen | 281.63 Mn | 281.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 9.50 Mn |
| Dec 31, 2023 | 9.50 Mn |
| Sep 30, 2023 | 17.00 Mn |
| Sep 30, 2023 | 17.00 Mn |
| Jun 30, 2023 | 28.17 Mn |
| Jun 30, 2023 | 28.17 Mn |
| Mar 31, 2023 | 25.50 Mn |
| Mar 31, 2023 | 25.50 Mn |
| Dec 31, 2022 | 10.77 Mn |
| Dec 31, 2022 | 10.77 Mn |
| Sep 30, 2022 | 43.87 Mn |
| Sep 30, 2022 | 43.87 Mn |
| Jun 30, 2022 | 14.00 Mn |
| Jun 30, 2022 | 14.00 Mn |
| Dec 31, 2021 | 1.10 Mn |
| Dec 31, 2021 | 1.10 Mn |
| Sep 30, 2021 | 4.40 Mn |
| Sep 30, 2021 | 4.40 Mn |